We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Revises Trasylol Labeling to Reflect Increased Risks
FDA Revises Trasylol Labeling to Reflect Increased Risks
December 15, 2006
The FDA approved revised labeling for Bayer’s Trasylol, adding a warning and limiting its approved usage to specific situations.